Navigated to What are the key safety warnings for Zepbound®?

Employers cover Calibrate. See if you’re eligible.

Frequently Asked Questions

Get answers to frequently asked questions about how Calibrate partners with your employer, what’s included, and more

Search For Your Employer

Dropdown closed

For Employers

Learn about Calibrate’s cost-effective and sustainable obesity care strategy

Dropdown closed

How It Works

Learn how Calibrate’s Metabolic Reset helps you lose weight and keep it off

Pricing

Understand what’s included in Calibrate’s Metabolic Reset; Starting at $199/month

Medications

Explore the GLP-1 medications Calibrate clinicians prescribe

Results

Calibrate drives sustained weight loss with real member results out to 3 years

Frequently Asked Questions

Find answers to common questions about Calibrate’s program, medications, and services

Get Started

Dropdown closed

Blog

- For Employers
  Learn about Calibrate’s cost-effective and sustainable obesity care strategy
Blog

Sign In
About Us
Careers
Press
Contact

What are the key safety warnings for Zepbound®?

Zepbound® carries a Boxed Warning for risk of medullary thyroid carcinoma (MTC) and should not be used in individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Cookie Usage

Our Website uses cookies to provide you with the best experience. Please select your preferences below. Learn more in our Privacy Policy.

NecessaryAlways active
Required for the site to function, including storing your cookie preferences.
Marketing & Analytics
Help us understand how you use our site and measure marketing performance. Includes Google Tag Manager, HubSpot, Microsoft Clarity, VWO, and Digioh.
Advertising
Used by our advertising and affiliate partners, including Commission Junction.